{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:14:15Z","timestamp":1785842055050,"version":"3.56.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2009,10,2]],"date-time":"2009-10-02T00:00:00Z","timestamp":1254441600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0007314","type":"journal-article","created":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T21:18:47Z","timestamp":1254431927000},"page":"e7314","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":84,"title":["MicroRNA Profiling of BRCA1\/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary"],"prefix":"10.1371","volume":"4","author":[{"given":"Cheng-Han","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbaya","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inigo","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Senz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley X.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"van de Rijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary.","volume":"351","author":"SA Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-8-17","article-title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.","volume":"8","author":"JZ Press","year":"2008","journal-title":"BMC Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.","volume":"92","author":"M Esteller","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.","volume":"104","author":"T Pal","year":"2005","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1525-1438.2006.00504.x","article-title":"BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study.","volume":"16","author":"M Thrall","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.","volume":"29","author":"G Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1073\/pnas.90.11.4961","article-title":"p53 gene mutations and protein accumulation in human ovarian cancer.","volume":"90","author":"J Kupryjanczyk","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","first-page":"2128","article-title":"p53 mutation is a common genetic event in ovarian carcinoma.","volume":"53","author":"BJ Milner","year":"1993","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.","volume":"5","author":"CP Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis.","volume":"19","author":"CP Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ygyno.2008.05.010","article-title":"Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.","volume":"110","author":"S Salvador","year":"2008","journal-title":"Gynecol Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1158\/0008-5472.CAN-05-0298","article-title":"MicroRNA biogenesis and cancer.","volume":"65","author":"RI Gregory","year":"2005","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2353\/ajpath.2007.070070","article-title":"MicroRNAs in tumorigenesis: a primer.","volume":"171","author":"W Zhang","year":"2007","journal-title":"Am J Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1101\/gad.1399806","article-title":"Control of translation and mRNA degradation by miRNAs and siRNAs.","volume":"20","author":"MA Valencia-Sanchez","year":"2006","journal-title":"Genes Dev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.","volume":"353","author":"GA Calin","year":"2005","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1476-4598-6-60","article-title":"OncomiRs: the discovery and progress of microRNAs in cancers.","volume":"6","author":"WC Cho","year":"2007","journal-title":"Mol Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer.","volume":"6","author":"A Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref18","article-title":"MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.","author":"IA Asangani","year":"2007","journal-title":"Oncogene"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/carcin\/bgn172","article-title":"A functional polymorphism in the miR-146a gene and age of familial breast\/ovarian cancer diagnosis.","volume":"29","author":"J Shen","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.1137999","article-title":"Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.","volume":"315","author":"C Mayr","year":"2007","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.","volume":"133","author":"F Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1158\/0008-5472.CAN-07-2462","article-title":"MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.","volume":"67","author":"VB Sampson","year":"2007","journal-title":"Cancer Res"},{"key":"ref23","first-page":"1161","article-title":"MicroRNA and ovarian cancer.","volume":"23","author":"DC Corney","year":"2008","journal-title":"Histol Histopathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e2436","DOI":"10.1371\/journal.pone.0002436","article-title":"MicroRNA expression and identification of putative miRNA targets in ovarian cancer.","volume":"3","author":"N Dahiya","year":"2008","journal-title":"PLoS ONE"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","article-title":"MicroRNA signatures in human ovarian cancer.","volume":"67","author":"MV Iorio","year":"2007","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1158\/1078-0432.CCR-07-1731","article-title":"MicroRNA expression profiles in serous ovarian carcinoma.","volume":"14","author":"EJ Nam","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.","volume":"68","author":"H Yang","year":"2008","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1073\/pnas.0801615105","article-title":"Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.","volume":"105","author":"L Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e5311","DOI":"10.1371\/journal.pone.0005311","article-title":"Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.","volume":"4","author":"SK Wyman","year":"2009","journal-title":"PLoS One"},{"key":"ref30","first-page":"4811","article-title":"Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.","volume":"9","author":"KK Zorn","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref31","article-title":"MicroRNA expression signature of human sarcomas.","author":"S Subramanian","year":"2007","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microRNA expression atlas based on small RNA library sequencing.","volume":"129","author":"P Landgraf","year":"2007","journal-title":"Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.","volume":"164","author":"M Shih Ie","year":"2004","journal-title":"Am J Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1158\/0008-5472.CAN-07-1585","article-title":"MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.","volume":"67","author":"DC Corney","year":"2007","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","article-title":"A microRNA component of the p53 tumour suppressor network.","volume":"447","author":"L He","year":"2007","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2007.10.028","article-title":"p53 enters the microRNA world.","volume":"12","author":"H Hermeking","year":"2007","journal-title":"Cancer Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers.","volume":"435","author":"J Lu","year":"2005","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1017\/S146239940800077X","article-title":"Critical molecular abnormalities in high-grade serous carcinoma of the ovary.","volume":"10","author":"M Kobel","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours.","volume":"9","author":"L Dubeau","year":"2008","journal-title":"Lancet Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","article-title":"Precursors to pelvic serous carcinoma and their clinical implications.","volume":"113","author":"AK Folkins","year":"2009","journal-title":"Gynecol Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact.","volume":"26","author":"K Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/IGC.0b013e3181a1b5dc","article-title":"High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy.","volume":"19","author":"JE Hirst","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.","volume":"31","author":"DW Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/modpathol.3800827","article-title":"Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mullerian system origin?","volume":"20","author":"GX Tong","year":"2007","journal-title":"Mod Pathol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-4598-5-29","article-title":"Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.","volume":"5","author":"E Bandres","year":"2006","journal-title":"Mol Cancer"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer.","volume":"65","author":"MV Iorio","year":"2005","journal-title":"Cancer Res"},{"key":"ref47","first-page":"882","article-title":"Reduced accumulation of specific microRNAs in colorectal neoplasia.","volume":"1","author":"MZ Michael","year":"2003","journal-title":"Mol Cancer Res"},{"key":"ref48","article-title":"Widespread deregulation of microRNA expression in human prostate cancer.","author":"M Ozen","year":"2007","journal-title":"Oncogene"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1349-7006.2007.00618.x","article-title":"Downregulation of microRNAs-143 and -145 in B-cell malignancies.","volume":"98","author":"Y Akao","year":"2007","journal-title":"Cancer Sci"},{"key":"ref50","first-page":"845","article-title":"MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers.","volume":"16","author":"Y Akao","year":"2006","journal-title":"Oncol Rep"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ygyno.2004.11.039","article-title":"Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.","volume":"96","author":"CB Gilks","year":"2005","journal-title":"Gynecol Oncol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nrc2232","article-title":"microRNAs join the p53 network\u2013another piece in the tumour-suppression puzzle.","volume":"7","author":"L He","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.pas.0000166367.68459.7d","article-title":"An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2\/neu, and C-KIT in high-grade neoplasms.","volume":"29","author":"CJ O'Neill","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ng1034","article-title":"Post-analysis follow-up and validation of microarray experiments.","author":"RF Chuaqui","year":"2002","journal-title":"Nat Genet 32 Suppl"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2144\/04364ST02","article-title":"Comparison of mRNA gene expression by RT-PCR and DNA microarray.","volume":"36","author":"W Etienne","year":"2004","journal-title":"Biotechniques"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1251\/bpo126","article-title":"Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR.","volume":"8","author":"JS Morey","year":"2006","journal-title":"Biol Proced Online"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/nar\/29.1.152","article-title":"The Stanford Microarray Database.","volume":"29","author":"G Sherlock","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns.","volume":"95","author":"MB Eisen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response.","volume":"98","author":"VG Tusher","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.","volume":"120","author":"BP Lewis","year":"2005","journal-title":"Cell"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","article-title":"MicroRNA targeting specificity in mammals: determinants beyond seed pairing.","volume":"27","author":"A Grimson","year":"2007","journal-title":"Mol Cell"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0007314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T18:25:26Z","timestamp":1633976726000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0007314"}},"subtitle":[],"editor":[{"given":"Amanda Ewart","family":"Toland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,2]]},"references-count":61,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,10,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0007314","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,2]]}}}